1. Home
  2. AXTA vs PTGX Comparison

AXTA vs PTGX Comparison

Compare AXTA & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Axalta Coating Systems Ltd.

AXTA

Axalta Coating Systems Ltd.

HOLD

Current Price

$32.03

Market Cap

6.3B

ML Signal

HOLD

Logo Protagonist Therapeutics Inc.

PTGX

Protagonist Therapeutics Inc.

HOLD

Current Price

$97.01

Market Cap

6.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AXTA
PTGX
Founded
1910
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Paints/Coatings
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.3B
6.4B
IPO Year
2014
2016

Fundamental Metrics

Financial Performance
Metric
AXTA
PTGX
Price
$32.03
$97.01
Analyst Decision
Buy
Strong Buy
Analyst Count
14
13
Target Price
$35.23
$108.23
AVG Volume (30 Days)
2.7M
462.9K
Earning Date
04-30-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.42
0.05
Revenue
$5,117,000,000.00
N/A
Revenue This Year
$3.60
$874.25
Revenue Next Year
$3.26
N/A
P/E Ratio
$75.64
$2,055.80
Revenue Growth
N/A
N/A
52 Week Low
$24.94
$49.86
52 Week High
$35.72
$107.84

Technical Indicators

Market Signals
Indicator
AXTA
PTGX
Relative Strength Index (RSI) 68.92 47.17
Support Level $31.21 $96.36
Resistance Level $32.39 $104.85
Average True Range (ATR) 0.99 4.25
MACD 0.32 -0.26
Stochastic Oscillator 82.91 42.59

Price Performance

Historical Comparison
AXTA
PTGX

About AXTA Axalta Coating Systems Ltd.

Axalta Coating Systems Ltd is a manufacturer, marketer, and distributor of high-performance coatings systems. It operates in two segments: Performance Coatings and Mobility Coatings. The Performance Coatings segment provides liquid and powder coatings solutions to a fragmented and local customer base. Its end markets include refinish and industrial, and the Mobility Coatings segment relates to the provision of coating technologies to original equipment manufacturers of light and commercial vehicles. The majority of its revenue is generated from the Mobility Coatings segment. Geographically, the company generates maximum revenue from the Europe, Middle East and Africa (EMEA) region, followed by North America, Asia Pacific, and Latin America.

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.

Share on Social Networks: